GRI Bio (GRI) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.40, +0.00% vs the prior close of $1.40.
- Volume 28.50K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GRI ends flat (+0.0%) to $1.40, 4 down days in a row. Closed at $1.40, +0.00% vs the prior close of $1.40. Day range $1.38–$1.45, opened at $1.43.
GRI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — GRI ends flat (+0.0%) to $1.40, 4 down days in a row
- Closed at $1.40, +0.00% vs the prior close of $1.40. Day range $1.38–$1.45, opened at $1.43.
- Volume was 28.50K shares, 0.1x its 50-day average of 412.51K — lighter than usual.
- Price is -25.2% vs its 50-day average ($1.87) and -45.3% vs its 200-day average ($2.56).
- 52-week range $1.36–$64.12; today's close sits at 0% of that range, 97.8% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — GRI slides 9.7% to $1.40, a 1-month low, 3 down days in a row
- Closed at $1.40, -9.68% vs the prior close of $1.55. Day range $1.40–$1.56, opened at $1.54.
- Volume was 50.50K shares, 0.1x its 50-day average of 412.41K — lighter than usual.
- Price is -25.3% vs its 50-day average ($1.87) and -45.9% vs its 200-day average ($2.59).
- 52-week range $1.36–$64.12; today's close sits at 0% of that range, 97.8% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — GRI dips 1.3% to $1.55, a 1-month low
- Closed at $1.55, -1.27% vs the prior close of $1.57. Day range $1.52–$1.60, opened at $1.60.
- Volume was 28.90K shares, 0.1x its 50-day average of 412.27K — lighter than usual.
- Price is -17.5% vs its 50-day average ($1.88) and -40.9% vs its 200-day average ($2.62).
- 52-week range $1.36–$64.12; today's close sits at 0% of that range, 97.6% below the 52-week high.
Oct 12, 2026 — GRI slides 9.8% to $1.57, a 1-month low
- Closed at $1.57, -9.77% vs the prior close of $1.74. Day range $1.55–$1.75, opened at $1.75.
- Volume was 64.50K shares, 0.2x its 50-day average of 411.46K — lighter than usual.
- Price is -16.3% vs its 50-day average ($1.88) and -40.9% vs its 200-day average ($2.66).
- 52-week range $1.36–$64.12; today's close sits at 0% of that range, 97.6% below the 52-week high.
Oct 9, 2026 — GRI jumps 3.6% to $1.74
- Closed at $1.74, +3.57% vs the prior close of $1.68. Day range $1.70–$1.76, opened at $1.71.
- Volume was 21.30K shares, 0.1x its 50-day average of 411.59K — lighter than usual.
- Price is -7.1% vs its 50-day average ($1.87) and -35.5% vs its 200-day average ($2.70).
- 52-week range $1.36–$64.12; today's close sits at 1% of that range, 97.3% below the 52-week high.
Oct 8, 2026 — GRI slides 9.2% to $1.68, a 1-month low, 5 down days in a row
- Closed at $1.68, -9.19% vs the prior close of $1.85. Day range $1.68–$1.88, opened at $1.85.
- Volume was 54.50K shares, 0.1x its 50-day average of 411.00K — lighter than usual.
- Price is -10.0% vs its 50-day average ($1.87) and -38.6% vs its 200-day average ($2.74).
- 52-week range $1.36–$64.12; today's close sits at 1% of that range, 97.4% below the 52-week high.
- That makes 5 straight losses.
Oct 7, 2026 — GRI dips 2.6% to $1.85, 4 down days in a row
- Closed at $1.85, -2.63% vs the prior close of $1.90. Day range $1.85–$1.92, opened at $1.88.
- Volume was 31.50K shares, 0.1x its 50-day average of 410.78K — lighter than usual.
- Price is -0.6% vs its 50-day average ($1.86) and -33.3% vs its 200-day average ($2.78).
- 52-week range $1.36–$64.12; today's close sits at 1% of that range, 97.1% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — GRI dips 0.5% to $1.90, 3 down days in a row
- Closed at $1.90, -0.52% vs the prior close of $1.91. Day range $1.88–$1.98, opened at $1.91.
- Volume was 18.20K shares, 0.0x its 50-day average of 410.87K — lighter than usual.
- Price is +2.5% vs its 50-day average ($1.85) and -32.6% vs its 200-day average ($2.82).
- 52-week range $1.36–$64.12; today's close sits at 1% of that range, 97.0% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — GRI dips 2.6% to $1.91
- Closed at $1.91, -2.55% vs the prior close of $1.96. Day range $1.88–$2.04, opened at $2.04.
- Volume was 84.60K shares, 0.2x its 50-day average of 409.78K — lighter than usual.
- Price is +3.6% vs its 50-day average ($1.84) and -33.4% vs its 200-day average ($2.87).
- 52-week range $1.36–$64.12; today's close sits at 1% of that range, 97.0% below the 52-week high.
Oct 2, 2026 — GRI ends flat (+0.0%) to $1.96
- Closed at $1.96, +0.00% vs the prior close of $1.96. Day range $1.95–$2.02, opened at $2.00.
- Volume was 38.40K shares, 0.1x its 50-day average of 409.31K — lighter than usual.
- Price is +6.9% vs its 50-day average ($1.83) and -33.0% vs its 200-day average ($2.92).
- 52-week range $1.36–$64.12; today's close sits at 1% of that range, 96.9% below the 52-week high.
GRI latest news & SEC filings
Every SEC filing by or about GRI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Sep 28, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.64M (prior year -$2.89M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.91 (prior year -$36.72) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade GRI
- Last results release: May 14, 2026 (8-K Item 2.02). Previous ones: Feb 4, 2026, May 15, 2025, Mar 17, 2025. Based on that rhythm, the next report is likely around Aug 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.61% (largest 9.8%). That is a volatile stock.
- Liquidity: about 66.44K shares (≈$93.01K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.40 vs a range of $1.36–$64.12 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:28 on Jan 26, 2026, 1:17 on Feb 24, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 8, 2026; 10-Q Aug 14, 2026; 8-K Jun 18, 2026.
- Share count: 2.19M shares outstanding (Aug 13, 2026), -13.1% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
GRI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.43 | 1.45 | 1.38 | 1.40 | 28.50K |
| Oct 14, 2026 | 1.54 | 1.56 | 1.40 | 1.40 | 50.50K |
| Oct 13, 2026 | 1.60 | 1.60 | 1.52 | 1.55 | 28.90K |
| Oct 12, 2026 | 1.75 | 1.75 | 1.55 | 1.57 | 64.50K |
| Oct 9, 2026 | 1.71 | 1.76 | 1.70 | 1.74 | 21.30K |
| Oct 8, 2026 | 1.85 | 1.88 | 1.68 | 1.68 | 54.50K |
| Oct 7, 2026 | 1.88 | 1.92 | 1.85 | 1.85 | 31.50K |
| Oct 6, 2026 | 1.91 | 1.98 | 1.88 | 1.90 | 18.20K |
| Oct 5, 2026 | 2.04 | 2.04 | 1.88 | 1.91 | 84.60K |
| Oct 2, 2026 | 2.00 | 2.02 | 1.95 | 1.96 | 38.40K |
| Oct 1, 2026 | 1.93 | 1.97 | 1.91 | 1.96 | 20.30K |
| Sep 30, 2026 | 2.05 | 2.05 | 1.92 | 1.93 | 35.40K |
| Sep 29, 2026 | 2.09 | 2.11 | 2.00 | 2.00 | 25.60K |
| Sep 28, 2026 | 2.07 | 2.25 | 2.00 | 2.10 | 118.10K |
| Sep 25, 2026 | 2.07 | 2.08 | 1.95 | 2.05 | 53.30K |
| Sep 24, 2026 | 2.13 | 2.18 | 2.03 | 2.09 | 31.00K |
| Sep 23, 2026 | 2.05 | 2.19 | 1.95 | 2.15 | 143.40K |
| Sep 22, 2026 | 1.96 | 2.06 | 1.93 | 2.05 | 106.50K |
| Sep 21, 2026 | 2.00 | 2.19 | 1.85 | 1.94 | 260.80K |
| Sep 18, 2026 | 1.86 | 1.96 | 1.77 | 1.93 | 113.40K |
About GRI Bio
GRI Bio (GRI) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LA JOLLA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1824293.
GRI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
GRI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-11.96M | -121.80 | $-10.19M |
| Dec 31, 2024 | — | $-8.21M | -1,545.55 | $-8.61M |
| Dec 31, 2023 | — | $-13.04M | -5,018.09 | $-8.99M |
| Dec 31, 2022 | — | $-3.22M | -24.95 | $-1.08M |
| Dec 31, 2021 | $0 | $-9.30M | -1.42 | $-8.31M |
Latest balance sheet: total assets $11.38M, total liabilities $1.10M, cash $10.95M (as of Jun 30, 2026).
GRI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 14, 2026 | 8-K Item 2.02 (results) | $2.15 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $2.64 |
| May 15, 2025 | 8-K Item 2.02 (results) | $40.60 |
| Mar 17, 2025 | 8-K Item 2.02 (results) | $157.36 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $456.96 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
| Nov 15, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
| Feb 24, 2023 | 8-K Item 2.02 (results) | — |
| Nov 3, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on GRI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.